CompareAEYE HealthvsDigital Diagnostics

AEYE Health is an AI retinal diagnostics company providing autonomous and assistive analysis for diabetic retinopathy screening in primary care settings. The product is positioned around retinal screening and care routing rather than ophthalmologist replacement, and specialist follow-up remains essential for every positive screen surfaced through the workflow. Buyers should confirm regulatory clearance, camera and imaging hardware compatibility, downstream referral integration, and program reporting before launching diabetic eye screening across primary care sites today.

AEYE Health works best for primary care diabetic retinopathy screening. The product's edge is lightweight retinal screening deployment, though buyers must accept that buyer scope is narrower than imaging ai giants. Pricing is sales-led and scoped per buyer rather than posted publicly. Run a small pilot to confirm fit before committing to a wider rollout.

Digital Diagnostics is an autonomous AI medical device company best known for IDx-DR, an autonomous system that screens for diabetic retinopathy from retinal images. The product is positioned around retinal screening and care routing rather than ophthalmologist replacement, and specialist follow-up remains essential for every positive screen surfaced through the workflow. Buyers should confirm regulatory clearance, camera and imaging hardware compatibility, downstream referral integration, and program reporting before launching diabetic eye screening across primary care sites today.

For primary care diabetic eye screening sites, Digital Diagnostics is worth a serious look thanks to pioneering autonomous diagnostic ai device. The honest trade-off is that regulatory scope is condition-specific. Pricing is sales-led and scoped per buyer rather than posted publicly. Buyers should still verify EHR or workflow fit, scope, and support before committing.